Loading...
Not a good buy right now for an impatient investor. ULS is trading $70.23 post-market (down -1.35% regular session) and sitting right on key support (S1 ~70.32) but still below the pivot (73.14), with bearish momentum not fully reversed. Options positioning is bullish (call-skewed), and fundamentals are solid, yet heavy insider selling and a more neutral/valuation-aware analyst stance reduce near-term upside confidence. I would wait for a reclaim of the pivot (~73+) or a cleaner momentum turn before buying.
Price/levels: ULS at 70.23 is below the pivot (73.144) and essentially at S1 (70.317); a clean break below S1 raises downside risk toward S2 (68.57). Upside resistance sits at R1 (~75.97).
Momentum: MACD histogram is negative (-0.62) but contracting, suggesting bearish momentum is fading (early stabilization), not a confirmed uptrend.
RSI: RSI_6 is ~21, which is typically oversold (despite the feed labeling it “neutral”), implying a potential short-term bounce risk/reward only if support holds.
Trend posture: Converging moving averages = consolidation/transition, but currently still below key pivot, so the technical setup is “weak-to-stabilizing,” not “buy-now.”
Pattern odds (model): Similar-pattern stats imply modestly negative near-term drift (next week -1.79%, next month -1.07%).
Intellectia Proprietary Trading Signals

on 2026-02-23 pre-market (EPS est. 0.
could re-rate the stock if results/guide beat again.
Analyst/valuation tone: JPMorgan downgraded to Neutral citing valuation after a large rally; risk/reward viewed as less compelling.
Latest quarter: 2025/Q3. Growth: Revenue $783M (+7.11% YoY) and EPS $0.49 (+11.36% YoY) show steady top-line growth with faster earnings growth. Profitability: Net income $100M (+13.64% YoY) and gross margin 50.32% (+2.76% YoY) indicate improving efficiency/mix—constructive underlying fundamentals.
Recent changes (2025-11-05):